Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DataMEDS AIMEDS -3.35% Median PS Value is $0.00 as of Jul. 26, 2026. The stock has 6 warning signs investors should review. Among 70 Medical Distribution companies, DataMEDS AI ranks worse than 1428570% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. DataMEDS AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $9.945. DataMEDS AI's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.
As of today (2026-07-26), DataMEDS AI's share price is $3.17. DataMEDS AI's Median PS Value is $0.00. Therefore, DataMEDS AI's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for DataMEDS AI's Median PS Value or its related term are showing as below:
MEDS's Price-to-Median-PS-Value is not ranked *
in the Medical Distribution industry.
Industry Median: 0.84 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
DataMEDS AI (NAS:MEDS) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
DataMEDS AI's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3.17
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DataMEDS AI Median PS Value Related Terms
DataMEDS AI Median PS Value Historical Data
* Premium members only.
The historical data trend for DataMEDS AI's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDS vs HEWA, BLMH, PMHS: Median PS Value Comparison
For the Medical Distribution subindustry, DataMEDS AI's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DataMEDS AI Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, DataMEDS AI's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where DataMEDS AI's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
DataMEDS AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.945.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DataMEDS AI (MEDS) has a Median PS Value of $0.00 as of Jul. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on DataMEDS AI and its competitors. According to the industry distribution chart, DataMEDS AI ranks #999999 out of 70 companies in the Medical Distribution industry.
Is DataMEDS AI's Median PS Value too high?
DataMEDS AI's current Median PS Value is $0.00. Based on the distribution chart, DataMEDS AI ranks #999999 out of 70 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does DataMEDS AI's Median PS Value compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #999999 out of 70 companies for Median PS Value. This places DataMEDS AI in the lower half of its industry. The industry median Median PS Value is 0.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.84, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on DataMEDS AI and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DataMEDS AI's current Median PS Value is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Median PS Value of $0.00. The current Median PS Value is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Median PS Value is $0.00 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDS has been successfully added to your 
